Harvard Corp., the powerful body that oversees the richest and oldest US university, selected lawyer Kannon Shanmugam to ...

Constellation Energy (CEG) has inked a 20-year deal to provide tech giant Meta Platforms (META) with power from its clean ...

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields. Merck KGaA (Merck), headquartered in Darmstadt, Germany, and Israel ...

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Pharmaceutical giant Merck will close its plant in Northumberland County, Pennsylvania. According to a ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. But with promising early results from a phase 3 study in certain ...

May 8 (Reuters) - Merck Animal Health, a unit of Merck (MRK.N), opens new tab, said on Thursday it would invest $895 million to expand its manufacturing facility in De Soto, Kansas. The capital ...

RAHWAY, N.J., May 08, 2025--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the broader biopharma industry. For the full year, Merck now expects ...

SHANGHAI, May 14 (Reuters) - German healthcare and materials group Merck KGaA (MRCG.DE), opens new tab has dropped a surcharge on life sciences sector orders within China following the U.S.-China ...

DURHAM, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to ...

Merck Animal Health is expanding its manufacturing facility in De Soto, Kansas with an $895 million investment. The capital expansion will be constructed on an existing Merck-owned property that ...

Merck (NYSE:MRK) announced Thursday that its bestselling therapy, Keytruda, as part of a combination regimen, reached the primary endpoint in a Phase 3 trial for a certain type of ovarian cancer ...